Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 2
Out of 5,055 analysts
133
Total ratings
67.02%
Success rate
162.56%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DGX Quest Diagnostics | Maintains: Buy | $200 → $215 | $186.95 | +15.00% | 3 | Oct 21, 2025 | |
| WAT Waters | Maintains: Buy | $435 → $385 | $379.40 | +1.48% | 8 | Aug 4, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $155 | $146.82 | +5.57% | 8 | May 29, 2025 | |
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $128.06 | -37.53% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $21.34 | +106.19% | 6 | May 8, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Hold | $1,200 → $1,100 | $1,403.08 | -21.60% | 8 | May 5, 2025 | |
| DHR Danaher | Maintains: Overweight | $280 → $260 | $221.21 | +17.54% | 3 | Apr 22, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $275 → $290 | $266.89 | +8.66% | 2 | Feb 6, 2025 | |
| NEO NeoGenomics | Initiates: Buy | $22 | $10.34 | +112.77% | 1 | Dec 10, 2024 | |
| HOLX Hologic | Initiates: Hold | $85 | $74.15 | +14.63% | 7 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $43 → $56 | $44.32 | +25.50% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $26.87 | +30.26% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $125 | $92.73 | +34.80% | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $15.89 | +51.04% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.61 | +148.45% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $1.80 | +66.67% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $204.28 | -30.49% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $94.37 | -66.09% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $120.67 | -4.70% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $6.72 | +197.84% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $578.71 | +12.32% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $15.64 | -42.46% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.21 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $2.00 | +500.00% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $5.75 | +944.39% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $4.31 | +433.64% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $167.81 | +132.41% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $2.31 | +679.22% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $549.51 | -63.60% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $19.40 | +23.71% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $10.52 | +327.76% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $152.40 | -54.07% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $220.61 | -45.61% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.04 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $41.62 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $12.32 | +346.43% | 1 | Jul 19, 2016 |
Quest Diagnostics
Oct 21, 2025
Maintains: Buy
Price Target: $200 → $215
Current: $186.95
Upside: +15.00%
Waters
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $379.40
Upside: +1.48%
Agilent Technologies
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $146.82
Upside: +5.57%
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $128.06
Upside: -37.53%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $21.34
Upside: +106.19%
Mettler-Toledo International
May 5, 2025
Upgrades: Hold
Price Target: $1,200 → $1,100
Current: $1,403.08
Upside: -21.60%
Danaher
Apr 22, 2025
Maintains: Overweight
Price Target: $280 → $260
Current: $221.21
Upside: +17.54%
Labcorp Holdings
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $266.89
Upside: +8.66%
NeoGenomics
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $10.34
Upside: +112.77%
Hologic
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $74.15
Upside: +14.63%
Dec 10, 2024
Assumes: Buy
Price Target: $43 → $56
Current: $44.32
Upside: +25.50%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $26.87
Upside: +30.26%
Jul 29, 2024
Maintains: Hold
Price Target: $115 → $125
Current: $92.73
Upside: +34.80%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $15.89
Upside: +51.04%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.61
Upside: +148.45%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $1.80
Upside: +66.67%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $204.28
Upside: -30.49%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $94.37
Upside: -66.09%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $120.67
Upside: -4.70%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $6.72
Upside: +197.84%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $578.71
Upside: +12.32%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $15.64
Upside: -42.46%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.21
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $2.00
Upside: +500.00%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $5.75
Upside: +944.39%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $4.31
Upside: +433.64%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $167.81
Upside: +132.41%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $2.31
Upside: +679.22%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $549.51
Upside: -63.60%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $19.40
Upside: +23.71%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $10.52
Upside: +327.76%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $152.40
Upside: -54.07%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $220.61
Upside: -45.61%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $1.04
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $41.62
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $12.32
Upside: +346.43%